Sildenafil Citrate Tablet
Product Images NDC 72789-404

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Sildenafil Citrate (NDC 72789-404). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Pd-rx Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

72789404 Label (72789404)

This is a description for a pharmaceutical product with the NDC code 72789-404-30. It is a blue tablet containing Sildenafil, each tablet is 25 mg. The package contains 30 tablets with a recommended dosage of one tablet several times a day. It is important to consult a doctor for medical advice on possible side effects and also report any side effects to the FDA. The tablets expire on 10/2025.*

FDA Label Image

Sildenafil-citrate-figure-1 (Sildenafil Citrate Figure 1)

FDA Label Image

Sildenafil-citrate-figure-2 (Sildenafil Citrate Figure 2)

This text provides information about the mean standing systolic blood pressure change from baseline. It appears to be a part of a figure or chart related to a study or research involving blood pressure measurements.*

FDA Label Image

Sildenafil-citrate-figure-3 (Sildenafil Citrate Figure 3)

This is a report or data table showing the change in mean standing systolic blood pressure from the baseline for individuals taking Doxazosin, Placebo, and Sildesatil 50 mg for a specific duration. The table includes numerical values for blood pressure readings at different time points.*

FDA Label Image

Sildenafil-citrate-figure-4 (Sildenafil Citrate Figure 4)

This is a figure showing the mean standing systolic blood pressure change from baseline after administration of Doxazosin. The graph displays the blood pressure readings in response to the medication over time.*

FDA Label Image

Sildenafil-citrate-figure-5 (Sildenafil Citrate Figure 5)

Description: A graph displaying the mean Sildenafil plasma concentrations in healthy male volunteers is shown in Figure 5.*

FDA Label Image

Sildenafil-citrate-figure-6 (Sildenafil Citrate Figure 6)

FDA Label Image

Sildenafil-citrate-figure-7 (Sildenafil Citrate Figure 7)

This appears to be a list of numerical values and medication names related to an assessment or evaluation process. The medication mentioned is likely Sildenafil citrate. The information provided seems to be related to measurements and dosages for the medication. Treatment approval might be a part of the assessment process described in the text.*

FDA Label Image

Sildenafil-citrate-structure (Sildenafil Citrate Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.